Resource type: Peer-reviewed journal
Total results with these characteristics: 633
- Economic Evaluations of Rotavirus Immunization for Developing Countries: A Review of the Literature
This article, published in Expert Review of Vaccines, analyzes the cost-effectiveness of universal rotavirus immunization in developing countries. The authors identified and evaluated 15 cost-effectiveness studies conducted in the developing world. …
Author: Tu HA, Woerdenbag HJ, Kane S, Rozenbaum MH, Li SC, Postma MJ
- Economic Impact of a Rotavirus Vaccination Program in Mexico
This article, published in the Pan American Journal of Public Health, examines a national rotavirus vaccination program in Mexico and evaluates its costs and benefits. The article concludes that the program would be highly cost-effective and …
Author: Constenla D, Velázquez FR, Rheingans RD, Antil L, Cervantes Y
- Effect of a Conjugate Pneumococcal Vaccine on the Occurrence of Respiratory Infections and Antibiotic Use in Day-Care Center Attendees
Published in the Pediatric Infectious Disease Journal, this article examines whether the use of a pneumococcal conjugate vaccine could reduce the occurrence of respiratory infections and the ensuing antibiotic drug use in the day care. In this …
Author: Dagan R, Sikuler-Cohen M, Zamir O, et al.
- Effect of a Serogroup A Meningococcal Conjugate Vaccine (PsA—TT) on Serogroup A Meningococcal Meningitis and Carriage in Chad: A Community Study
A serogroup A meningococcal polysaccharide—tetanus toxoid conjugate vaccine (PsA—TT, MenAfriVac) was licensed in India in 2009, and prequalified by the World Health Organization in 2010, on the basis of its safety and immunogenicity. This …
Author: Daugla DM, Gami JP, Gamougam K, et al.
- Effect of Combined Pneumococcal Conjugate and Polysaccharide Vaccination on Recurrent Otitis Media with Effusion
Published in the journal Pediatrics, this article assess the effect of combined pneumococcal conjugate and polysaccharide vaccinations on the recurrence of otitis media through a randomised, controlled trial.
Author: van Heerbeek N, Straetemans M, Wiertsema SP
- Effect of Human Rotavirus Vaccine on Severe Diarrhea in African Infants
This article, published in The New England Journal of Medicine, discusses a study on the efficacy of rotavirus vaccine in Africa. Results showed 30.2 percent efficacy against all-cause severe gastroenteritis. The study concluded that rotavirus …
Author: Madhi SA, Cunliffe NA, Steele D, et al.
- Effect of Multiple, Simultaneous Vaccines on Polio Seroresponse and Associated Health Outcomes
This article, published in Vaccine, compared vaccination with inactivated polio vaccine (IPV) alone or simultaneously with one other vaccine to vaccination with IPV and four other vaccines among adults in the United States military. The results …
Author: Broderick MP, Oberste MS, Moore D, Romero-Steiner S, Hansen CJ, Faix DJ
- Effect of Rotavirus Vaccination on Death From Childhood Diarrhea in Mexico
This article, published in The New England Journal of Medicine, discusses a study on the effectiveness of rotavirus vaccine in Mexico. The study examined the impact of vaccination on diarrheal deaths in Mexican children between 2008 and 2009 …
Author: Richardson V, Hernandez-Pichardo J, Quintanar-Solares M, et al.
- Effect of Rotavirus Vaccine on Diarrhea Mortality in Different Socioeconomic Regions of Mexico
This article, published in Pediatrics, concludes that after the 2007 introduction of rotavirus vaccine in Mexico, marked and sustained declines in diarrhea deaths were seen among children in all regions of the country, including in the least …
Author: Gastañaduy PA, Sánchez-Uribe E, Esparza-Aguilar M, et al.
- Effect of Single Dose of SA 14-14-2 Vaccine One Year After Immunisation in Nepalese Children with Japanese Encephalitis: A Case-Control Study
Published in The Lancet, investigators conducted a case-control study and efficacy of the SA 14-14-2 JE vaccine to be 98.5 percent 12 to 15 months after vaccination. ABSTRACT ONLY. (Learn how users in developing countries can gain free access …
Author: Ohrr H, Tandan JB, Sohn YM, et al.
- Effect of Vaccines on Bacterial Meningitis Worldwide
This article, published in The Lancet, focuses on the three most common causes of acute bacterial meningitis: Haemophilus influenzae, Streptococcus pneumoniae, and Neisseria meningitidis. The authors compare patterns of meningitis attributable to …
Author: McIntyre PB, O'Brien KL, Greenwood B, van de Beek D
- Effectively Introducing a New Meningococcal A Conjugate Vaccine in Africa: The Burkina Faso Experience
In 2010, Burkina Faso conducted a country-wide campaign to introduce a new Group A meningococcal conjugate vaccine, MenAfriVac™. Leading up to this effort, the following challenges were successfully managed: (1) conducting a large safety study …
Author: Djingarey MH, Barry R, Bonkoungou M, et al.
- Effectiveness of an Indian-made Attenuated Influenza A(H1N1)pdm 2009 Vaccine: A Case Control Study
This article, published in Human Vaccines & Immunotherapeutics, details a case control study to evaluate the effectiveness of a live attenuated A(H1N1)pdm 2009 vaccine produced by the Serum Institute of India, Ltd., which was distributed in …
Author: Kulkarni PS, Agarkhedkar S, Lalwani S, et al.
- Effectiveness of Haemophilus influenzae type b Conjugate Vaccine on Prevention of Pneumonia and Meningitis in Bangladeshi Children: A Case-Control Study
Few Asian countries have introduced Haemophilus influenzae type b (Hib) conjugate vaccine because of its cost and uncertainty regarding disease burden. To estimate the effectiveness of Hib conjugate vaccine in preventing pneumonia and meningitis in …
Author: Baqui AH, El Arifeen S, Saha SK, et al.
- Effectiveness of Maternal Influenza Immunization in Mothers and Infants
Young infants and pregnant women are at increased risk for serious consequences of influenza infection. Inactivated influenza vaccine is recommended for pregnant women but is not licensed for infants younger than six months of age. This study …
Author: Zaman K, Roy E, Arifeen S, et al.
- Effectiveness of Meningococcal Serogroup C Vaccine Programmes
Since the introduction of monovalent meningococcal serogroup C (MenC) glycoconjugate (MCC) vaccines and the implementation of national vaccination programs, the incidence of MenC disease has declined markedly as a result of effective short-term …
Author: Borrow R, Abad R, Trotter C, van der Kils FRM, Vazquez JA
- Effectiveness of Monovalent Rotavirus Vaccine in Bolivia: Case-Control Study
This article, published in BMJ, reports on a study that evaluated the effectiveness of two doses of a monovalent rotavirus vaccine against hospital admission for rotavirus at six hospitals in Bolivia, between March 2010 and June 2011. Results show …
Author: Patel MM, Patzi M, Pastor D, et al.
- Effectiveness of One Dose of SA 14-14-2 Vaccine Against Japanese Encephalitis
Correspondence, published in the New England Journal of Medicine, about a small case control study in Uttar Pradesh, India, on the efficacy of a single dose of the SA 14-14-2 JE vaccine within six months of its administration. …
Author: Kumar R, Tripathi P, Rizvi A
- Effectiveness of Pentavalent and Monovalent Rotavirus Vaccines in Concurrent Use Among US Children <5 Years of Age, 2009–2011
This article, published in Clinical Infectious Diseases, summarizes a study that assessed vaccine effectiveness of RotaTeq (RV5; 3 doses) and Rotarix (RV1; 2 doses) at reducing rotavirus acute gastroenteritis inpatient and emergency department (ED) …
Author: Payne DC, Boom JA, Staat MA, et al.
- Efficacy and Safety of Human Papillomavirus Vaccine for Primary Prevention of Cervical Cancer: A Review of Evidence From Phase III Trials and National Programs
This article, published in the South Asian Journal of Cancer, discusses the justification of human papillomavirus (HPV) vaccination in the backdrop of the natural history of cervical cancer, the mechanism of action of the vaccines, and efficacy and …
Author: Basu P, Banerjee D, Singh P, Bhattacharya C, Biswas J
- Efficacy and Safety of the RTS,S/AS01 Malaria Vaccine During 18 Months After Vaccination: A Phase 3 Randomized, Controlled Trial in Children and Young Infants at 11 African Sites
This article, published in PLoS Medicine, reports on follow-up data from a Phase 3 trial conducted to test the effectiveness of the malaria vaccine candidate RTS,S/AS01 in children and young infants. RTS,S/AS01 prevented many cases of clinical and …
Author: RTS,S Clinical Trials Partnership
- Efficacy of a Monovalent Human-Bovine (116E) Rotavirus Vaccine in Indian Infants: A Randomised, Double-Blind, Placebo-Controlled Trial
This article, published in The Lancet, reports on the results of a Phase 3 study to assess the efficacy and tolerability of a monovalent human-bovine rotavirus vaccine (116E) for severe rotavirus gastroenteritis in low-resource urban and rural …
Author: Bhandari N, Rongsen-Chandola T, Bavdekar A, et al.
- Efficacy of a Pneumococcal Conjugate Vaccine Against Acute Otitis Media
This study, published in the New England Journal of Medicine, enrolled 1662 infants in a randomized, double-blind efficacy trial of a heptavalent pneumococcal polysaccharide conjugate vaccine in which the carrier protein is the nontoxic …
Author: Eskola J, Kilpi T, Palmu A, et al.
- Efficacy of Human Rotavirus Vaccine Against Rotavirus Gastroenteritis During the First 2 Years of Life in European Infants: Randomised, Double-Blind Controlled Study
This article, published in The Lancet, presents data that show high efficacy for GSK's Rotarix® administered with routine vaccines. Over two seasons, Rotarix® demonstrated 90 percent efficacy against severe rotavirus among European …
Author: Vesikari T, Karvonen A, Prymula R, et al.
- Efficacy of Nine-valent Pneumococcal Conjugate Vaccine Against Pneumonia and Invasive Pneumococcal Disease in The Gambia: Randomized Double-Blind, Placebo-Controlled Trial
Published in The Lancet, this study aims to assess the efficacy of a nine-valent pneumococcal conjugate vaccine in children through a randomised, placebo-controlled, double-blind trial in eastern Gambia. Children age 6–51 weeks were randomly …
Author: Cutts U, Zaman SMA, Enwere G, et al.